PSMA-PET to Guide Prostatectomy

Clinical Trials, High Risk Prostate Cancer, Intermediate Risk Prostate Cancer

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05381103
Phase: Phase 2|Phase 3
Trial Summary: In this study, 288 patients will be randomized 1:1 to either having only the standard of care MRI prior to surgery versus having the standard of care MRI and the PSMA PET scan. PET – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Five Eleven Pharma, Inc.
Acronym:

Pin It on Pinterest